← Eichor
Study identifier: NCT06242379 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

Condition: Retinitis Pigmentosa  ·  Sponsor: Mahidol University

PhasePhase 1/Phase 2
Planned participants15
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this clinical trials is to evaluate the safety and efficacy of intravitreal injection of GMP-compliant BM-MSC-derived sEVs in patients with retinitis pigmentosa.

This description comes directly from the study's public registry record.

Talk to the study team

Laongsri Atchaneeyasakul, Professor  ·  +66 893138367  ·  atchanee@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Siriraj HospitalBangkok Noi, Bangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06242379